for Journals by Title or ISSN
for Articles by Keywords
help

Publisher: Medknow Publishers   (Total: 425 journals)

 A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

        1 2 3 | Last   [Sort by number of followers]   [Restore default list]

Showing 1 - 200 of 425 Journals sorted alphabetically
Acta Medica Intl.     Open Access   (SJR: 0.101, CiteScore: 0)
Advanced Arab Academy of Audio-Vestibulogy J.     Open Access  
Advanced Biomedical Research     Open Access  
Advances in Human Biology     Open Access   (Followers: 4)
Advances in Skeletal Muscle Function Assessment     Open Access  
African J. for Infertility and Assisted Conception     Open Access   (Followers: 1)
African J. of Medical and Health Sciences     Open Access   (Followers: 3)
African J. of Paediatric Surgery     Open Access   (Followers: 7, SJR: 0.25, CiteScore: 1)
African J. of Trauma     Open Access   (Followers: 1)
Ain-Shams J. of Anaesthesiology     Open Access   (Followers: 2)
Al-Azhar Assiut Medical J.     Open Access   (Followers: 2)
Al-Basar Intl. J. of Ophthalmology     Open Access   (Followers: 1)
Alexandria J. of Pediatrics     Open Access   (Followers: 1)
Ancient Science of Life     Open Access   (Followers: 5)
Anesthesia : Essays and Researches     Open Access   (Followers: 10)
Annals of African Medicine     Open Access   (Followers: 2, SJR: 0.258, CiteScore: 1)
Annals of Bioanthropology     Open Access   (Followers: 5)
Annals of Cardiac Anaesthesia     Open Access   (Followers: 14, SJR: 0.308, CiteScore: 1)
Annals of Indian Academy of Neurology     Open Access   (Followers: 3, SJR: 0.434, CiteScore: 1)
Annals of Indian Academy of Otorhinolaryngology Head and Neck Surgery     Open Access  
Annals of Indian Psychiatry     Open Access  
Annals of Maxillofacial Surgery     Open Access   (Followers: 6)
Annals of Medical and Health Sciences Research     Open Access   (Followers: 7)
Annals of Nigerian Medicine     Open Access   (Followers: 1)
Annals of Pediatric Cardiology     Open Access   (Followers: 12, SJR: 0.352, CiteScore: 1)
Annals of Saudi Medicine     Open Access   (SJR: 0.238, CiteScore: 1)
Annals of Thoracic Medicine     Open Access   (Followers: 6, SJR: 0.524, CiteScore: 1)
Annals of Tropical Medicine and Public Health     Open Access   (Followers: 13, SJR: 0.152, CiteScore: 0)
Annals of Tropical Pathology     Open Access  
Apollo Medicine     Open Access  
APOS Trends in Orthodontics     Open Access   (Followers: 1)
Arab J. of Interventional Radiology     Open Access   (Followers: 1)
Archives of Cardiovascular Imaging     Open Access   (Followers: 2, SJR: 0.187, CiteScore: 0)
Archives of Intl. Surgery     Open Access   (Followers: 10, SJR: 0.302, CiteScore: 1)
Archives of Medicine and Health Sciences     Open Access   (Followers: 4)
Archives of Medicine and Surgery     Open Access  
Archives of Pharmacy Practice     Open Access   (Followers: 10, SJR: 0.102, CiteScore: 0)
Archives of Trauma Research     Open Access   (Followers: 3, SJR: 0.37, CiteScore: 2)
Asia Pacific J. of Clinical Trials : Nervous System Diseases     Open Access  
Asia-Pacific J. of Oncology Nursing     Open Access   (Followers: 5)
Asian J. of Andrology     Open Access   (Followers: 1, SJR: 0.856, CiteScore: 2)
Asian J. of Neurosurgery     Open Access   (Followers: 2)
Asian J. of Oncology     Open Access   (Followers: 2)
Asian J. of Transfusion Science     Open Access   (Followers: 1, SJR: 0.35, CiteScore: 1)
Asian Pacific J. of Reproduction     Open Access   (SJR: 0.227, CiteScore: 1)
Asian Pacific J. of Tropical Biomedicine     Open Access   (Followers: 2, SJR: 0.491, CiteScore: 2)
Asian Pacific J. of Tropical Medicine     Open Access   (Followers: 1, SJR: 0.561, CiteScore: 2)
Astrocyte     Open Access  
Avicenna J. of Medicine     Open Access   (Followers: 1)
AYU : An international quarterly journal of research in Ayurveda     Open Access   (Followers: 6)
Benha Medical J.     Open Access  
Biomedical and Biotechnology Research J.     Open Access   (Followers: 1)
BLDE University J. of Health Sciences     Open Access  
Brain Circulation     Open Access   (Followers: 1)
Bulletin of Faculty of Physical Therapy     Open Access   (Followers: 2)
Canadian J. of Rural Medicine     Full-text available via subscription   (Followers: 1, SJR: 0.202, CiteScore: 0)
Cancer Translational Medicine     Open Access   (Followers: 2)
Cardiology Plus     Open Access   (Followers: 1)
Chinese Medical J.     Open Access   (Followers: 10, SJR: 0.52, CiteScore: 1)
CHRISMED J. of Health and Research     Open Access   (Followers: 2)
Clinical Cancer Investigation J.     Open Access  
Clinical Dermatology Review     Open Access   (Followers: 4)
Clinical Trials in Degenerative Diseases     Open Access  
Clinical Trials in Orthopedic Disorders     Open Access  
Community Acquired Infection     Open Access  
Conservation and Society     Open Access   (Followers: 8, SJR: 0.811, CiteScore: 2)
Contemporary Clinical Dentistry     Open Access   (Followers: 5, SJR: 0.353, CiteScore: 1)
Current Medical Issues     Open Access   (Followers: 1)
CytoJ.     Open Access   (Followers: 2, SJR: 0.543, CiteScore: 1)
Delta J. of Ophthalmology     Open Access  
Dental Hypotheses     Open Access   (Followers: 4, SJR: 0.152, CiteScore: 0)
Dental Research J.     Open Access   (Followers: 13, SJR: 0.416, CiteScore: 1)
Dentistry and Medical Research     Open Access   (Followers: 1)
Digital Medicine     Open Access  
Drug Development and Therapeutics     Open Access  
Education for Health     Open Access   (Followers: 7, SJR: 0.242, CiteScore: 0)
Egyptian J. of Bronchology     Open Access  
Egyptian J. of Cardiothoracic Anesthesia     Open Access  
Egyptian J. of Cataract and Refractive Surgery     Open Access   (Followers: 1, SJR: 1.799, CiteScore: 2)
Egyptian J. of Chest Diseases and Tuberculosis     Open Access   (Followers: 3, SJR: 0.155, CiteScore: 0)
Egyptian J. of Dermatology and Venerology     Open Access   (Followers: 1)
Egyptian J. of Haematology     Open Access   (Followers: 1)
Egyptian J. of Internal Medicine     Open Access   (Followers: 1)
Egyptian J. of Obesity, Diabetes and Endocrinology     Open Access   (Followers: 1)
Egyptian J. of Otolaryngology     Open Access   (Followers: 2)
Egyptian J. of Psychiatry     Open Access   (Followers: 1)
Egyptian J. of Surgery     Open Access   (Followers: 1)
Egyptian Nursing J.     Open Access  
Egyptian Orthopaedic J.     Open Access   (Followers: 2)
Egyptian Pharmaceutical J.     Open Access   (Followers: 3)
Egyptian Retina J.     Open Access  
Egyptian Rheumatology and Rehabilitation     Open Access   (Followers: 2)
Endodontology     Open Access  
Endoscopic Ultrasound     Open Access   (SJR: 0.822, CiteScore: 2)
Environmental Disease     Open Access   (Followers: 4)
Eurasian J. of Pulmonology     Open Access  
European J. of Dentistry     Open Access   (Followers: 4, SJR: 0.749, CiteScore: 2)
European J. of General Dentistry     Open Access   (Followers: 2, SJR: 0.12, CiteScore: 0)
European J. of Prosthodontics     Open Access   (Followers: 4)
European J. of Psychology and Educational Studies     Open Access   (Followers: 11, SJR: 0.113, CiteScore: 0)
Fertility Science and Research     Open Access  
Formosan J. of Surgery     Open Access   (SJR: 0.112, CiteScore: 0)
Genome Integrity     Open Access   (Followers: 2, SJR: 0.153, CiteScore: 0)
Glioma     Open Access  
Global J. of Transfusion Medicine     Open Access   (Followers: 1)
Gynecology and Minimally Invasive Therapy     Open Access   (SJR: 0.311, CiteScore: 1)
Hamdan Medical J.     Open Access  
Heart and Mind     Open Access  
Heart India     Open Access   (Followers: 2)
Heart Views     Open Access   (Followers: 2)
Hepatitis B Annual     Open Access   (Followers: 3)
Ibnosina J. of Medicine and Biomedical Sciences     Open Access   (Followers: 1)
IJS Short Reports     Open Access  
Imam J. of Applied Sciences     Open Access  
Indian Dermatology Online J.     Open Access   (Followers: 3)
Indian J. of Allergy, Asthma and Immunology     Open Access   (Followers: 1)
Indian J. of Anaesthesia     Open Access   (Followers: 7, SJR: 0.478, CiteScore: 1)
Indian J. of Burns     Open Access   (Followers: 1)
Indian J. of Cancer     Open Access   (Followers: 1, SJR: 0.361, CiteScore: 1)
Indian J. of Cerebral Palsy     Open Access   (Followers: 1)
Indian J. of Community Medicine     Open Access   (Followers: 2, SJR: 0.37, CiteScore: 1)
Indian J. of Dental Research     Open Access   (Followers: 5, SJR: 0.266, CiteScore: 1)
Indian J. of Dental Sciences     Open Access  
Indian J. of Dentistry     Open Access   (Followers: 1)
Indian J. of Dermatology     Open Access   (Followers: 2, SJR: 0.468, CiteScore: 1)
Indian J. of Dermatology, Venereology and Leprology     Open Access   (Followers: 4, SJR: 0.445, CiteScore: 1)
Indian J. of Dermatopathology and Diagnostic Dermatology     Open Access  
Indian J. of Drugs in Dermatology     Open Access   (Followers: 1, SJR: 0.791, CiteScore: 1)
Indian J. of Endocrinology and Metabolism     Open Access   (Followers: 4, SJR: 0.568, CiteScore: 1)
Indian J. of Health Sciences and Biomedical Research KLEU     Open Access   (Followers: 3)
Indian J. of Medical and Paediatric Oncology     Open Access   (SJR: 0.425, CiteScore: 1)
Indian J. of Medical Microbiology     Open Access   (Followers: 2, SJR: 0.503, CiteScore: 1)
Indian J. of Medical Research     Open Access   (Followers: 4, SJR: 0.656, CiteScore: 1)
Indian J. of Medical Sciences     Open Access   (Followers: 2, SJR: 0.102, CiteScore: 0)
Indian J. of Multidisciplinary Dentistry     Open Access   (Followers: 1)
Indian J. of Nephrology     Open Access   (Followers: 2, SJR: 0.347, CiteScore: 1)
Indian J. of Nuclear Medicine     Open Access   (Followers: 2, SJR: 0.23, CiteScore: 0)
Indian J. of Occupational and Environmental Medicine     Open Access   (Followers: 3, SJR: 0.225, CiteScore: 1)
Indian J. of Ophthalmology     Open Access   (Followers: 4, SJR: 0.498, CiteScore: 1)
Indian J. of Oral Health and Research     Open Access  
Indian J. of Oral Sciences     Open Access   (Followers: 1)
Indian J. of Orthopaedics     Open Access   (Followers: 8, SJR: 0.392, CiteScore: 1)
Indian J. of Otology     Open Access   (Followers: 1, SJR: 0.199, CiteScore: 0)
Indian J. of Paediatric Dermatology     Open Access   (Followers: 2)
Indian J. of Pain     Open Access   (Followers: 2)
Indian J. of Palliative Care     Open Access   (Followers: 6, SJR: 0.454, CiteScore: 1)
Indian J. of Pathology and Microbiology     Open Access   (Followers: 3, SJR: 0.276, CiteScore: 1)
Indian J. of Pharmacology     Open Access   (SJR: 0.412, CiteScore: 1)
Indian J. of Psychiatry     Open Access   (Followers: 2, SJR: 0.408, CiteScore: 1)
Indian J. of Psychological Medicine     Open Access   (SJR: 0.368, CiteScore: 1)
Indian J. of Public Health     Open Access   (Followers: 1)
Indian J. of Radiology and Imaging     Open Access   (Followers: 4)
Indian J. of Research in Homoeopathy     Open Access  
Indian J. of Respiratory Care     Open Access  
Indian J. of Rheumatology     Open Access   (Followers: 1, SJR: 0.119, CiteScore: 0)
Indian J. of Sexually Transmitted Diseases and AIDS     Open Access   (Followers: 2, SJR: 0.34, CiteScore: 0)
Indian J. of Social Psychiatry     Open Access   (Followers: 1)
Indian J. of Transplantation     Open Access  
Indian J. of Urology     Open Access   (Followers: 4, SJR: 0.434, CiteScore: 1)
Indian J. of Vascular and Endovascular Surgery     Open Access   (Followers: 2)
Indian Spine J.     Open Access  
Industrial Psychiatry J.     Open Access   (Followers: 2)
Intervention     Open Access   (Followers: 1)
Intl. Archives of Health Sciences     Open Access  
Intl. J. of Abdominal Wall and Hernia Surgery     Open Access   (Followers: 1)
Intl. J. of Academic Medicine     Open Access  
Intl. J. of Advanced Medical and Health Research     Open Access  
Intl. J. of Applied and Basic Medical Research     Open Access  
Intl. J. of Clinical and Experimental Physiology     Open Access   (Followers: 1)
Intl. J. of Clinicopathological Correlation     Open Access   (Followers: 1)
Intl. J. of Community Dentistry     Open Access  
Intl. J. of Critical Illness and Injury Science     Open Access   (Followers: 1, SJR: 0.192, CiteScore: 0)
Intl. J. of Educational and Psychological Researches     Open Access   (Followers: 4)
Intl. J. of Environmental Health Engineering     Open Access   (Followers: 1)
Intl. J. of Forensic Odontology     Open Access   (Followers: 1)
Intl. J. of Green Pharmacy     Open Access   (Followers: 8, SJR: 0.142, CiteScore: 0)
Intl. J. of Growth Factors and Stem Cells in Dentistry     Open Access  
Intl. J. of Health & Allied Sciences     Open Access   (Followers: 3)
Intl. J. of Health System and Disaster Management     Open Access   (Followers: 3)
Intl. J. of Heart Rhythm     Open Access  
Intl. J. of Medicine and Public Health     Open Access   (Followers: 6)
Intl. J. of Mycobacteriology     Open Access   (SJR: 0.535, CiteScore: 1)
Intl. J. of Noncommunicable Diseases     Open Access  
Intl. J. of Nutrition, Pharmacology, Neurological Diseases     Open Access   (Followers: 4, SJR: 0.17, CiteScore: 0)
Intl. J. of Oral Health Sciences     Open Access   (Followers: 3)
Intl. J. of Orofacial Biology     Open Access   (Followers: 1)
Intl. J. of Orofacial Research     Open Access   (Followers: 2)
Intl. J. of Orthodontic Rehabilitation     Open Access   (Followers: 1)
Intl. J. of Pedodontic Rehabilitation     Open Access  
Intl. J. of Pharmaceutical Investigation     Open Access   (Followers: 2)
Intl. J. of Preventive Medicine     Open Access   (Followers: 1, SJR: 0.623, CiteScore: 1)
Intl. J. of Shoulder Surgery     Open Access   (Followers: 5, SJR: 0.653, CiteScore: 1)
Intl. J. of the Cardiovascular Academy     Open Access   (SJR: 0.105, CiteScore: 0)
Intl. J. of Trichology     Open Access   (SJR: 0.4, CiteScore: 1)
Intl. J. of Yoga     Open Access   (Followers: 15)
Intl. J. of Yoga : Philosophy, Psychology and Parapsychology     Open Access   (Followers: 6)
Iranian J. of Nursing and Midwifery Research     Open Access   (Followers: 3)
Iraqi J. of Hematology     Open Access  
J. of Academy of Medical Sciences     Open Access  
J. of Acute Disease     Open Access   (SJR: 0.163, CiteScore: 1)

        1 2 3 | Last   [Sort by number of followers]   [Restore default list]

Similar Journals
Journal Cover
Indian Journal of Rheumatology
Journal Prestige (SJR): 0.119
Number of Followers: 1  

  This is an Open Access Journal Open Access journal
ISSN (Print) 0973-3698 - ISSN (Online) 0973-3701
Published by Medknow Publishers Homepage  [425 journals]
  • Addressing the unmet needs in medical training for alarmingly widening
           demand–supply gap in rheumatic diseases: A tale of two countries

    • Authors: Shivani Garg, Ram Raj Singh
      Pages: 167 - 171
      Abstract: Shivani Garg, Ram Raj Singh
      Indian Journal of Rheumatology 2019 14(3):167-171

      Citation: Indian Journal of Rheumatology 2019 14(3):167-171
      PubDate: Wed,30 Oct 2019
      DOI: 10.4103/injr.injr_100_3
      Issue No: Vol. 14, No. 3 (2019)
       
  • Rheumatology teaching and training in India – From
           procrastination to implementation!

    • Authors: Rohini Handa
      Pages: 172 - 173
      Abstract: Rohini Handa
      Indian Journal of Rheumatology 2019 14(3):172-173

      Citation: Indian Journal of Rheumatology 2019 14(3):172-173
      PubDate: Wed,30 Oct 2019
      DOI: 10.4103/injr.injr_110_19
      Issue No: Vol. 14, No. 3 (2019)
       
  • Critical workforce challenges and the impact of rheumatic and
           musculoskeletal diseases: Urgent call for action

    • Authors: Sharad Lakhanpal, Akshai Lakhanpal
      Pages: 174 - 176
      Abstract: Sharad Lakhanpal, Akshai Lakhanpal
      Indian Journal of Rheumatology 2019 14(3):174-176

      Citation: Indian Journal of Rheumatology 2019 14(3):174-176
      PubDate: Wed,30 Oct 2019
      DOI: 10.4103/injr.injr_600_3
      Issue No: Vol. 14, No. 3 (2019)
       
  • CAR T-cells to drive away autoimmunity in lupus

    • Authors: Sakir Ahmed
      Pages: 177 - 179
      Abstract: Sakir Ahmed
      Indian Journal of Rheumatology 2019 14(3):177-179

      Citation: Indian Journal of Rheumatology 2019 14(3):177-179
      PubDate: Wed,30 Oct 2019
      DOI: 10.4103/injr.injr_118_19
      Issue No: Vol. 14, No. 3 (2019)
       
  • Platelet activation markers in juvenile idiopathic arthritis

    • Authors: Pandiarajan Vignesh, Surjit Singh
      Pages: 180 - 181
      Abstract: Pandiarajan Vignesh, Surjit Singh
      Indian Journal of Rheumatology 2019 14(3):180-181

      Citation: Indian Journal of Rheumatology 2019 14(3):180-181
      PubDate: Wed,30 Oct 2019
      DOI: 10.4103/injr.injr_400_3
      Issue No: Vol. 14, No. 3 (2019)
       
  • Platelet microparticles level in juvenile idiopathic arthritis: A
           pediatric population-based cross-sectional study in a tertiary care center
           

    • Authors: Naresh Kumar, K Anu Punnen, Sukesh Chandran Nair, Visalakshi Jayaseelan, T Sathish Kumar
      Pages: 182 - 186
      Abstract: Naresh Kumar, K Anu Punnen, Sukesh Chandran Nair, Visalakshi Jayaseelan, T Sathish Kumar
      Indian Journal of Rheumatology 2019 14(3):182-186
      Background: Platelet-derived microparticles (PMPs) are small vesicles that are released from the plasma membrane upon platelet activation, which are then involved in haemostasis, vascular health, and have recently been shown to be intimately involved in immune responses.Aims and Objectives: We aimed to evaluate the level of plasma Platelet-derived micro particles in children with JIA and to assess the relationship between PMP levels and disease activity in JIA. Materials and Methods: Children with JIA who fulfilled the International League of Associations for Rheumatology (ILAR) classification criteria for juvenile idiopathic arthritis were included. They were categorised into active disease group and inactive disease as assessed by Wallace criteria. Samples were run in Navios flow cytometer (Beckman Coulter). Platelet microparticles were identified by MPs positive for both Annexin V and CD41 antibodies. Results: Out of 26 children with JIA, 12 had active disease group and 14 had inactive disease as assessed by Wallace criteria. Mean PMP level was 83507 cells/μl and 34904 cells/μl in active and inactive disease respectively (P = 0.06). There was no significant correlation between PMP and CRP levels (P = 0.75 and r = 0 .102) or PMP and ESR levels (P = 0.56 and r = -0.186) in JIA children with active disease.Conclusion: PMP levels were significantly elevated in disease activity of JIA and could represent a new biomarker reflecting the state of cell activation in JIA. PMP role in the inflammatory processes needs to be further elucidated.
      Citation: Indian Journal of Rheumatology 2019 14(3):182-186
      PubDate: Wed,30 Oct 2019
      DOI: 10.4103/injr.injr_10_19
      Issue No: Vol. 14, No. 3 (2019)
       
  • Conventional synthetic disease-modifying antirheumatic drug use by
           race/ethnicity and factors associated with initiating biologics in
           Malaysian patients with rheumatoid arthritis

    • Authors: Suad Mohammed, Lydia Say Lee Pok, Ying Chew Tee, Fariz Yahya
      Pages: 187 - 193
      Abstract: Suad Mohammed, Lydia Say Lee Pok, Ying Chew Tee, Fariz Yahya
      Indian Journal of Rheumatology 2019 14(3):187-193
      Aims: The aim of the study was to evaluate the treatment patterns of conventional synthetic disease-modifying antirheumatic drugs (csDMARDs), drug survival, and the factors in initiating biologic DMARDs based on race and ethnicity in rheumatoid arthritis (RA) patients.Materials and Methods: Data on RA patients, including race/ethnicity, who were attending University Malaya Medical Centre, Kuala Lumpur, Malaysia, and started on csDMARDs between January 2006 and December 2016, were collected retrospectively from the review of patients' medical records. Factors in initiating biologic DMARDs were identified.Results: A total of 369 RA patients received at least one csDMARD; 325 (88.1%) were female, and 271 (73.4%) were seropositive. Three main races were identified: Malay (28.7%), Chinese (33.1%), Indian (36.3%), and others (1.9%). Malay race patients were initiated on a csDMARD at a younger age (48.6 years, standard deviation [SD]: 12.4) due to younger age at onset compared to other races (P < 0.001). Overall, methotrexate was the most common csDMARD used, and 39 (11%) patients were on triple-combination therapy. Disease activity score 28–erythrocyte sedimentation rate improved at 3 months post-csDMARD treatment for all races (P < 0.001). Twenty-six (7%) patients received biologics, with a mean age at initiating first biologic of 49.8 (SD: 18.3) years. There were no significant differences in age at initiating first biologic between the race groups (P = 0.83). In fully adjusted models, race was not a factor in initiating biologics.Conclusion: CsDMARDs in RA were required at a younger age for a certain race due to younger age at onset. However, race does not predict the initiation of biologics and no significant difference in the use of combination csDMARDs between races.
      Citation: Indian Journal of Rheumatology 2019 14(3):187-193
      PubDate: Wed,30 Oct 2019
      DOI: 10.4103/injr.injr_74_19
      Issue No: Vol. 14, No. 3 (2019)
       
  • The impact of training through the telegram's virtual network on
           promoting women's knowledge and perceptions in preventing osteoporosis
           

    • Authors: Zohreh Karimiankakolaki, Maryam Khadibi, Sakineh Gerayllo, Bahareh Motaghi, Fatemeh Heidari
      Pages: 194 - 199
      Abstract: Zohreh Karimiankakolaki, Maryam Khadibi, Sakineh Gerayllo, Bahareh Motaghi, Fatemeh Heidari
      Indian Journal of Rheumatology 2019 14(3):194-199
      Introduction: Osteoporosis is the most common metabolic bone disease. Therefore, the present study was conducted to determine the effect of training through the Telegram network on increasing the knowledge and perceptions of women in preventing osteoporosis.Methods: This study was an educational intervention, pretest and posttest type with randomized control group. Sixty women who referred to the marginal health centers of Yazd were randomly selected and assigned to intervention and control groups. After completing the questionnaires, a package of educational messages was sent to the intervention group through the Telegram group. A month later, the questionnaires were completed again, and the data were analyzed by SPSS 18 software and Wilcoxon and Mann–Whitney test.Results: The mean age of participants in intervention and control groups was 30.46 ± 5.71 and 29.93 ± 5.02, respectively. The findings showed that the median score of knowledge (3 scores, P= 0.001) and subscales of women's beliefs (perceived sensitivity [1 score, P= 0.046], perceived severity [1 score, P= 0.001], perceived benefits [1.5 scores, P= 0.031], and cues to action [6 scores, P= 0.000]) increased significantly after intervention in the intervention group. The median score of knowledge was significantly higher than the control group (4 scores, P= 0.000).Conclusions: Use of Telegram training and virtual training spaces is effective in promoting women's knowledge and perceptions in the prevention of osteoporosis and contributes to the advancement of women's health beliefs. Therefore, the adoption of this type of training is recommended to overcome the limitations of traditional education in the prevention of osteoporosis.
      Citation: Indian Journal of Rheumatology 2019 14(3):194-199
      PubDate: Wed,30 Oct 2019
      DOI: 10.4103/injr.injr_70_19
      Issue No: Vol. 14, No. 3 (2019)
       
  • A study of serum YKL-40 and its correlation with traditional biomarkers in
           rheumatoid arthritis patients

    • Authors: Vinod Narayan, Vasanthi Pallinti, Nalini Ganesan
      Pages: 200 - 205
      Abstract: Vinod Narayan, Vasanthi Pallinti, Nalini Ganesan
      Indian Journal of Rheumatology 2019 14(3):200-205
      Background: This study was aimed to measure the serum levels of YKL-40 among early and late rheumatoid arthritis (RA) patients along with other disease activity measures in RA patients.Materials and Methods: It was a cross-sectional study involving 152 RA patients based on the 1987 American College of Rheumatology criteria for the diagnosis of RA and 68 age- and sex-matched healthy controls. The patient group was further subdivided into 75 early (<2 years disease duration) and 77 late (>2 years) RA patients based on the duration of the disease. Clinical examination was performed on RA patients, and traditional markers to measure the disease activity such as Disease Activity Score (DAS)-28, Visual Analog Score (VAS), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), anti-cyclic citrullinated peptide (CCP), and rheumatoid factor (RF) were assessed. Serum YKL-40 level was measured using ELISA method. All the values were expressed as median (25th–75th percentile).Results: In our study, there was a significant increase in serum YKL-40 level in RA patients (200.8 [141.24–282.7] ng/ml) compared to healthy controls (82.2 [49.01–123.78] ng/ml) with P < 0.001. There was no significant difference in serum YKL-40 levels among early and late RA patients. The traditional inflammatory markers such as ESR, CRP, and measures of disease activity such as DAS-28 and VAS were significantly increased in late RA patients than early RA (P < 0.001). Serum YKL-40 levels were not correlated with disease activity measures such as DAS-28, VAS, CRP, and ESR in RA patients.Conclusion: Serum YKL-40 level was significantly higher in RA. However there was no difference between early and late RA. It does not correlate with measures of disease activity.
      Citation: Indian Journal of Rheumatology 2019 14(3):200-205
      PubDate: Wed,30 Oct 2019
      DOI: 10.4103/injr.injr_44_19
      Issue No: Vol. 14, No. 3 (2019)
       
  • Correlation of disease activity score using erythrocyte sedimentation rate
           and C-reactive protein with clinical disease activity index in rheumatoid
           arthritis patients

    • Authors: Viraj Panchal, Puja Srivastava, Dhaiwat Shukla, Devang Rana, Supriya Malhotra, Sapan Pandya
      Pages: 206 - 210
      Abstract: Viraj Panchal, Puja Srivastava, Dhaiwat Shukla, Devang Rana, Supriya Malhotra, Sapan Pandya
      Indian Journal of Rheumatology 2019 14(3):206-210
      Background: Most patients coming to government hospital are from lower socioeconomic class and do not always get investigations done like ESR or CRP. A purely clinical index like CDAI would be a useful measure in such resource poor settings. Also there is scarce data on patterns of DMARD use from our country. Objectives: To compare Disease Activity Score 28 using erythrocyte sedimentation rate (DAS28-ESR) and Disease Activity Score 28 using C-reactive protein (DAS28-CRP) with CDAI (Clinical Disease activity index) as measures of disease activity of RA and to analyze prescription patterns in RA patients.Methods: Ours was a cross-sectional study of 4 months' duration. DAS28-ESR, DAS28-CRP and CDAI were calculated. The details of DMARDs used were recorded in proformas. Correlation was done using Spearman's Correlation Coefficient Test. To assess agreement between scores Cohen's kappa value was also evaluated. P value obtained <0.05 was considered significant. Results: We evaluated a total of 104 patients most of them being females with a mean age of 45 years. The mean DAS28-ESR was 4.59 ± 1.36, mean DAS28-CRP was 3.86 ± 1.25 and mean CDAI was 16.9 ± 9.26 . The correlation coefficients of DAS28-ESR with DAS28-CRP was 0.894, DAS28-ESR with CDAI was 0.886 and DAS28-CRP with CDAI was 0.910. Methotrexate was the most prescribed drug as a mono therapy or in a combination with Hydroxychloroquine followed by Leflunomide, Sulfasalazine, and Prednisolone in that order. Conclusion: The CDAI can substitute for SDAI or DAS 28 ESR/CRP and this would be very useful in a resource poor setting. Methotrexate was the most prescribed drug in our set up as mono or combination therapy.
      Citation: Indian Journal of Rheumatology 2019 14(3):206-210
      PubDate: Wed,30 Oct 2019
      DOI: 10.4103/injr.injr_37_19
      Issue No: Vol. 14, No. 3 (2019)
       
  • Standardizing initial dilution titers of antinuclear antibodies for the
           screening of systemic lupus erythematosus

    • Authors: Joseph Sushil Rao, Vineeta Shobha, Tinku Thomas, Usha Kini
      Pages: 211 - 217
      Abstract: Joseph Sushil Rao, Vineeta Shobha, Tinku Thomas, Usha Kini
      Indian Journal of Rheumatology 2019 14(3):211-217
      Background: Systemic Lupus Erythematosus (SLE), a systemic autoimmune disease, is diagnosed by correlating clinical features with a positive Antinuclear Antibody (ANA) test. Detection of ANA by Indirect Immunofluorescence (IIF) is used for screening SLE and is dependent on initial dilution titers which require population-specific standardization. With lack of exclusive commercial kits for the South Indian population, it is necessary to standardize initial screening dilution titers for ANA to distinguish SLE and other rheumatic diseases from the healthy. Methods: Newly diagnosed SLE patients between 18 and 60 years along with healthy controls from South India over 8 months (September 2015–April 2016) were selected for this prospective study. Serum samples were subjected to ANA-IIF in dilution titers of 1:40, 1:80, and 1:100 as per kit recommendations. IIF intensity and staining patterns were correlated clinically and statistically analyzed. Results: ANA positivity in dilutions of 1:40 and 1:80 was seen in 2.1% of healthy controls and negative at 1:100. About 97.9% of SLE patients were positive at 1:100 dilution; speckled pattern being the most common (52.1%), followed by homogeneous (37.4%). The patterns were best appreciated in 1:100 dilution with high significant measure of agreement of kappa between the two pathologists for both patterns and intensity at all three dilutions. Conclusion: 1:100 is the best screening dilution to distinguish SLE patterns from normal healthy individuals, and its main advantage is the delineation of various ANA patterns when positive, especially when mixed at this lower dilution.
      Citation: Indian Journal of Rheumatology 2019 14(3):211-217
      PubDate: Wed,30 Oct 2019
      DOI: 10.4103/injr.injr_172_18
      Issue No: Vol. 14, No. 3 (2019)
       
  • Recent advances in the management of antineutrophil cytoplasmic
           antibody-associated vasculitis

    • Authors: Durga Prasanna Misra, G SRSN K Naidu, Aman Sharma
      Pages: 218 - 228
      Abstract: Durga Prasanna Misra, G SRSN K Naidu, Aman Sharma
      Indian Journal of Rheumatology 2019 14(3):218-228
      The prognosis of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) has remarkably improved from an almost uniformly fatal disease about three decades back, to a chronic manageable disease with survival rates in excess of 80%. Induction of remission largely relies on cyclophosphamide or rituximab-based regimens, although emerging data suggest some potential role of mycophenolate mofetil (MMF), especially in milder disease phenotypes. Recent emphasis has shifted to exploration of treatment regimens minimizing dosage and duration of corticosteroid exposure, or replacing corticosteroids altogether with agents like avacopan, in an effort to ameliorate risks due to glucocorticoids as well as minimize damage accrual. Maintenance regimens traditionally have used azathioprine, methotrexate, or less commonly, MMF. However, rituximab is emerging as a useful maintenance agent, with the advantage of single-dose administration 6 monthly. Dosing interval for rituximab maintenance is another area of active research, with emerging literature suggesting the effectiveness of a dosing schedule based on B-cell repopulation or rise in ANCA titers. Long-term considerations for patients with AAV include the risk of infections (which can be minimized with alternate-day cotrimoxazole therapy), hypogammaglobulinemia in patients on rituximab, and accrual of damage, including drug-related damage (such as diabetes and osteoporosis) and malignancies. Ongoing clinical trials attempt to decipher the role of plasma exchange, as well as delineate the exact role of newer steroid-sparing therapeutic modalities such as avacopan. Recent clinical guidelines for the management of AAV from multiple societies, including the European League against Rheumatism and the British Society for Rheumatology, provide common treatment recommendations for AAV management.
      Citation: Indian Journal of Rheumatology 2019 14(3):218-228
      PubDate: Wed,30 Oct 2019
      DOI: 10.4103/injr.injr_141_19
      Issue No: Vol. 14, No. 3 (2019)
       
  • Acute pancreatitis in rheumatology practice, with emphasis on systemic
           lupus erythematosus: A case series and newer concepts

    • Authors: Praveen Pratap Jadhav, Saourabh Rajesh Desai, Janhavee Praveen Jadhav, Lata Sunil Bichile
      Pages: 229 - 235
      Abstract: Praveen Pratap Jadhav, Saourabh Rajesh Desai, Janhavee Praveen Jadhav, Lata Sunil Bichile
      Indian Journal of Rheumatology 2019 14(3):229-235
      Acute pancreatitis is seen in many rheumatological disorders, of which, systemic lupus erythematosus (SLE) is the most common. SLE is a multisystemic disease, affecting the gastrointestinal system in about half of the patients. Acute pancreatitis is a rare but life-threatening complication of SLE. Here, we report three intriguing cases of SLE wherein patients suffering from SLE presented with acute pancreatitis either as the initial symptom of the disease or as a flare. Another patient in this series is of dermatomyositis. Literature is reviewed, and newer concepts are discussed.
      Citation: Indian Journal of Rheumatology 2019 14(3):229-235
      PubDate: Wed,30 Oct 2019
      DOI: 10.4103/injr.injr_33_19
      Issue No: Vol. 14, No. 3 (2019)
       
  • Adenosine deaminase 2 deficiency with a novel variant of CECR1 gene
           mutation: Responding to tumor necrosis factor antagonist therapy

    • Authors: Zakiya Saleh Al Mosawi, Hiba Omar Abduljawad, Maryam Yusuf Busehail, Barrak Mahmood Al Moosawi
      Pages: 236 - 240
      Abstract: Zakiya Saleh Al Mosawi, Hiba Omar Abduljawad, Maryam Yusuf Busehail, Barrak Mahmood Al Moosawi
      Indian Journal of Rheumatology 2019 14(3):236-240
      Deficiency of Adenosine deaminase 2 (DADA2) syndrome is a chronic, systemic, and inflammatory disorder, characterized by early-onset recurrent strokes, fever, livedo reticularis, and immunodeficiency. We report the case of a 4-year-old child, a product of consanguineous marriage, who presented with three episodes of hemiparesis within 1 year. She also manifested skin discoloration in the form of livedo reticularis. Workup with magnetic resonance imaging (MRI) of the brain revealed acute infarction in the right aspect of the cerebral peduncle and chronic lacunars infarct in the right thalamus with diffusion restriction. Repeated MRI after 5 months revealed diffuse loss of brain volume. The blood workup showed high inflammatory markers and significantly low adenosine deaminase 2 (ADA2) level. After being on corticosteroid and anticoagulant treatments, she suffered from a recurrent episode of cerebral infarction, after which she was commenced on tumor necrosis factor (TNF)-antagonist therapy in addition to monthly fresh plasma infusion. Thereafter, there was no cerebral insult reported for >18 months. The genetic study of the child and her parents revealed a homozygous mutation c. 336C>A, p. (His112Gln) in the CECR1 gene, and her parents were heterozygous for the same variant. This variant was not previously reported in literature. We would suggest to link this novel variant c. 336C>A, p. (His112Gln) of CECR1 gene mutation with the clinical picture, along with the positive response to TNF-antagonist therapy in the era of ADA2 deficiency syndrome.
      Citation: Indian Journal of Rheumatology 2019 14(3):236-240
      PubDate: Wed,30 Oct 2019
      DOI: 10.4103/injr.injr_36_19
      Issue No: Vol. 14, No. 3 (2019)
       
  • Eosinophilic mastitis: A chameleon disease in rheumatologists&#39;
           domain

    • Authors: Shruti Bajad, Rohit Bajaj, Dhaval Tanna, Muzaffar Bindroo, Kanchan Kaur, Rajiva Gupta
      Pages: 241 - 243
      Abstract: Shruti Bajad, Rohit Bajaj, Dhaval Tanna, Muzaffar Bindroo, Kanchan Kaur, Rajiva Gupta
      Indian Journal of Rheumatology 2019 14(3):241-243
      We report a rare case of eosinophilic mastitis in a young asthmatic female who presented with a breast lump and was managed conservatively with a successful outcome. Eosinophilic mastitis, characterized by eosinophilic infiltration of mammary glands, is one such entity which is frequently given a miss, and is diagnosed based on histopathological analysis. The identification of this disease is a primary step in the management of such benign disorders which can be successfully treated conservatively avoiding any surgical intervention and morbidities thereafter. Because presentation can be similar and confusing enough, we took a cue from the history of asthma, urticaria, and peripheral eosinophilia to clinch the diagnosis of eosinophilic mastitis, which was further confirmed on biopsy. To the best of our knowledge, this happens to be the youngest female patient aged 27 years who also had urticaria along with other eosinophilic manifestations, which is unreported in other cases and makes our case exceptional. She was treated with glucocorticoids and antihistaminics and is presently symptom free.
      Citation: Indian Journal of Rheumatology 2019 14(3):241-243
      PubDate: Wed,30 Oct 2019
      DOI: 10.4103/injr.injr_39_19
      Issue No: Vol. 14, No. 3 (2019)
       
  • Spondyloarthritis associated with inflammatory myositis: An unusual case
           report

    • Authors: Pradip Kumar Prajapati
      Pages: 244 - 246
      Abstract: Pradip Kumar Prajapati
      Indian Journal of Rheumatology 2019 14(3):244-246
      Spondyloarthritis is an inflammatory disorder of the axial skeleton, while inflammatory myositis is an inflammatory disease affecting the striated muscles. There is no usual association of spondyloarthritis and inflammatory myositis. A 35-year-old female patient presented with proximal muscle weakness and lower back pain with a history of knee synovitis and was diagnosed to have axial spondyloarthritis with inflammatory myositis. Her radiological studies showed sacroiliitis with inflammatory edema in the thigh muscle, with laboratory investigations showing elevated levels of creatine phosphokinase and inflammatory markers and positive human leukocyte antigen B27. She responded well to treatment (prednisolone, methotrexate, analgesic, and supportive medicines) with normalization of laboratory parameters and improved clinically.
      Citation: Indian Journal of Rheumatology 2019 14(3):244-246
      PubDate: Wed,30 Oct 2019
      DOI: 10.4103/injr.injr_63_19
      Issue No: Vol. 14, No. 3 (2019)
       
  • Eyelid edema in relapsing polychondritis

    • Authors: Anshul Goel, Arun Gogna
      Pages: 247 - 249
      Abstract: Anshul Goel, Arun Gogna
      Indian Journal of Rheumatology 2019 14(3):247-249
      Relapsing polychondritis (RP) is a multisystem inflammatory disease affecting all types of cartilage and proteoglycan-rich tissues with recurrent bouts of inflammation resulting in tissue damage. The pleomorphic nature, the wide spectrum of clinical features and insidious onset of the disease makes the diagnosis of RP a challenge for clinicians. Eyelid edema is a recognized manifestation of this disease frequently in association with inflammation in other parts of eyes. This case highlights eyelid edema in a patient who presented primarily with chondritis of the pinna, which subsided with steroids.
      Citation: Indian Journal of Rheumatology 2019 14(3):247-249
      PubDate: Wed,30 Oct 2019
      DOI: 10.4103/injr.injr_6_19
      Issue No: Vol. 14, No. 3 (2019)
       
  • Fellowship in rheumatology

    • Authors: VR Joshi
      Pages: 250 - 250
      Abstract: VR Joshi
      Indian Journal of Rheumatology 2019 14(3):250-250

      Citation: Indian Journal of Rheumatology 2019 14(3):250-250
      PubDate: Wed,30 Oct 2019
      DOI: 10.4103/injr.injr_111_19
      Issue No: Vol. 14, No. 3 (2019)
       
  • Tocilizumab-induced anaphylactic reactions in rheumatic diseases:
           Consideration for clinicians with monoclonal antibody infusions

    • Authors: Amee D Pandya, Dhaiwat Shukla, Supriya D Malhotra, Pankaj Patel, Sapan Pandya
      Pages: 251 - 253
      Abstract: Amee D Pandya, Dhaiwat Shukla, Supriya D Malhotra, Pankaj Patel, Sapan Pandya
      Indian Journal of Rheumatology 2019 14(3):251-253

      Citation: Indian Journal of Rheumatology 2019 14(3):251-253
      PubDate: Wed,30 Oct 2019
      DOI: 10.4103/injr.injr_94_19
      Issue No: Vol. 14, No. 3 (2019)
       
  • Allergic-dermatological symptoms and psychological variables in
           fibromyalgia: A preliminary study of their relationship

    • Authors: Juan Antonio Becerra-Garcia
      Pages: 254 - 256
      Abstract: Juan Antonio Becerra-Garcia
      Indian Journal of Rheumatology 2019 14(3):254-256

      Citation: Indian Journal of Rheumatology 2019 14(3):254-256
      PubDate: Wed,30 Oct 2019
      DOI: 10.4103/injr.injr_81_19
      Issue No: Vol. 14, No. 3 (2019)
       
  • Ultrasound-guided suprascapular nerve block versus intra-articular steroid
           injection in adhesive capsulitis of shoulder: Comments on treatment
           options

    • Authors: Yeow Leng Tan, Jun Yin Lee
      Pages: 257 - 258
      Abstract: Yeow Leng Tan, Jun Yin Lee
      Indian Journal of Rheumatology 2019 14(3):257-258

      Citation: Indian Journal of Rheumatology 2019 14(3):257-258
      PubDate: Wed,30 Oct 2019
      DOI: 10.4103/injr.injr_116_19
      Issue No: Vol. 14, No. 3 (2019)
       
 
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
 
Home (Search)
Subjects A-Z
Publishers A-Z
Customise
APIs
Your IP address: 3.234.210.89
 
About JournalTOCs
API
Help
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-